Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study

Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study

Abstract Background Transarterial chemoembolization (TACE) is recommended as the standard care for unresectable hepatocellular carcinoma (HCC) at Barcelona Clinic Liver Cancer (BCLC) stage A–B. However, the efficacy of TACE on large (≥ 10 cm) stage A–B HCC is far from satisfactory, and it is propose...

Full description

Bibliographic Details
Main Authors: Min-Ke He, Yong Le, Qi-Jiong Li, Zi-Shan Yu, Shao-Hua Li, Wei Wei, Rong-Ping Guo, Ming Shi
Format: Article
Language:English
Published: BMC 2017-10-01
Series:Chinese Journal of Cancer
Subjects:
Hepatocellular carcinoma
Hepatic artery infusion chemotherapy
Transarterial chemoembolization
mFOLFOX
Online Access:http://link.springer.com/article/10.1186/s40880-017-0251-2

Internet

http://link.springer.com/article/10.1186/s40880-017-0251-2

Similar Items